Retinoblastomas are the most common intraocular neoplasm found in childhood and with modern treatment modalities, are, in most cases, curable.
On imaging, they are generally characterised by a heterogeneous retinal mass with calcifications, necrotic components and increased vascularisation on Doppler ultrasound/enhancement on CT/MRI.
On this page:
Epidemiology
Retinoblastomas may be sporadic or secondary to a germline mutation of the retinoblastoma protein tumour suppressor gene (RB), which is usually inherited. It may be unilateral or bilateral:
bilateral (30-40% of cases) essentially always have a germline mutation 5,6
unilateral tumours (60-70% of cases) are caused by a germline mutation in approximately 15% of cases, whereas 85% are sporadic 5,6
Thus, 39-50% of cases are due to a germline mutation. This mutation is inherited in an autosomal dominant fashion with ~90% penetrance (i.e. the child of a retinoblastoma survivor who has a germline mutation has a 50% chance of inheriting a mutation, and if they do so a 90% chance of developing retinoblastoma. They thus have an overall probability of 45% of having a retinoblastoma (50% × 90%).
Most cases are diagnosed within the first four years of life, with a median age of diagnosis of 18-24 months 5,6.
Children with germline mutations are also at increased risk of developing trilateral retinoblastoma (unilateral or bilateral retinoblastomas and pineoblastoma) 11, quadrilateral retinoblastoma (trilateral retinoblastoma and suprasellar CNS embryonal tumour) 14 and osteosarcoma 2,3 and usually present early (median age of diagnosis 12 months) 6.
Clinical presentation
Presentation is most frequently with leukocoria or loss of red-eye reflex, strabismus and decreased vision 15. Overall approximately 30-40% are bilateral and often synchronous. These almost always have a germline mutation and tend to occur at a younger age 5,6.
Pathology
Three patterns of growth are recognised 4,5:
-
endophytic
growth occurs inwards into the vitreous
cell clusters may detach and float in the vitreous (vitreous seeding)
-
exophytic
growth occurs outwards
associated with non-rhegmatogenous retinal detachment
combined endophytic and exophytic
Retinoblastoma may metastasise via direct spread into the orbit, along the optic nerve into the brain, or the subarachnoid space resulting in leptomeningeal metastases. It can also haematogenously metastasise preferentially to the bone, bone marrow and liver. Rarely, it will spread to regional lymph nodes 9.
Macroscopic appearance
Macroscopic and funduscopic examination reveals a white elevated mass with fine surface vessels 4.
Microscopic appearance
Histology demonstrates a small round-cell tumour of neuroepithelial origin. Flexner-Wintersteiner rosettes (relatively specific for retinoblastoma) and Homer-Wright pseudorosettes (also found in other PNETs) may be seen on microscopy.
Radiographic features
Ultrasound
Orbital sonography can be performed without sedation and can be repeated multiple times without exposing the child to ionising radiation. Retinoblastomas appear as echogenic soft-tissue masses with variable shadowing due to calcifications and heterogeneity due to necrosis and haemorrhage 5. At diagnosis, tumours are usually vascular on Doppler examination.
The vitreous may have multiple areas of "floating" debris, which may represent vitreous seeding or alternatively, necrotic debris, haemorrhage or increased globulin content 5.
CT
It must be emphasised that CT scan is not recommended in the study of children with suspected or known retinoblastoma 12. CT scan use may result in an increased risk of secondary malignancies related to radiation exposure. Moreover, high doses of radiation are especially harmful to patients with germline retinoblastoma 13.
However, when a CT study is performed for any other indication, it may demonstrate a contrast-enhancing retrolental mass that is usually calcified. A dense vitreous due to haemorrhage is also common.
MRI
MRI is the modality of choice for pre-treatment staging on retinoblastoma (see retinoblastoma staging) 4.
MRI is often used in searching for optic nerve involvement, extraocular extension, and the possibility of a concomitant primitive neuroectodermal tumour (trilateral retinoblastoma with pineoblastoma).
T1: intermediate signal intensity, hyperintense compared to the vitreous 4,5
T2: hypointense compared to the vitreous
-
T1 C+ (Gd)
the mass usually enhances relatively homogeneously when small
larger tumours are often heterogeneous due to areas of necrosis
linear enhancement of the choroid beyond the margins of the tumour should raise the possibility of choroidal involvement, although inflammation may lead to a similar appearance 4
enhancement of the anterior chamber need not represent tumour involvement, with hyperaemia, uveitis, and iris neovascularisation all leading to asymmetric enhancement 4
careful assessment of the optic disc and optic nerve should be carried out to assess for involvement
extra-ocular extension through the sclera will be visible as an interruption of the otherwise hypointense non-enhancing sclera by enhancing tumour
-
DWI/ADC
Treatment and prognosis
Treatment depends on tumour size and the stage of disease (see retinoblastoma staging) and involves one or more modalities:
-
conservative
external-beam radiation therapy
cryotherapy
laser photocoagulation
radioactive plaque therapy
thermochemotherapy
tumour reduction chemotherapy
-
surgical
enucleation
en bloc resection
Prognosis depends on the stage. Overall the cure rate has risen to over 90% in developed nations 4.
Patients with retinoblastoma rarely (<1%) go on to develop rhabdomyosarcoma, which itself perhaps arises due to chemotherapy, radiation therapy and/or an underlying genetic susceptibility 10.
Differential diagnosis
For imaging differentials consider:
differential for calcification of the globe
differential for an ocular mass
differential for ocular enlargement